SCHEMBL7301103

SCHEMBL7301103

COc1ccc(C=CC(=O)O)cc1OC1CCCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.69
ALDH1A1 P00352 2/20 0.69
HPGD P15428 1/20 0.69
ALOX15 P16050 1/20 0.69
MAPK1 P28482 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HSD17B10 Q99714 1/20 0.69
PDE4B Q07343 9/20 0.68
PDE4A P27815 5/20 0.68
PDE4C Q08493 5/20 0.68
PDE4D Q08499 5/20 0.68
SNCA P37840 2/20 0.58
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA3 P07451 1/20 0.58
PKM P14618 1/20 0.58
CSNK2A2 P19784 1/20 0.58
CA4 P22748 1/20 0.58
CA6 P23280 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301099 1.00 KDM4E (0.69) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL30025682 1.00 KDM4E (0.69) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL28496638 0.95 KDM4E (0.69) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL20809899 0.92 KDM4E (0.69) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7324806 0.90 PDE4B (0.60) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7324802 0.90 PDE4B (0.60) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7357136 0.90 PDE4B (0.68) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7332000 0.90 PDE4B (0.68) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7331992 0.90 PDE4B (0.68) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL7929068 0.90 PDE4B (0.68) KDM4EALDH1A1HPGDALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5274002-A 1-Oxy- or -thio-2-cycloalkyloxy-4-carboxyalkylene benzene derivatives WARNER-LAMBERT COMPANY (US) 1993-12-28 US claimed
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity UNIVERSITA DEGLI STUDI DI GENOVA (IT) 2018-07-10 US disclosed
EP-3105206-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY Universita' degli Studi di Genova (IT) 2016-12-21 EP disclosed
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY THE TRUSTEES OF COLUMBIA UNIVERSITY 2016-12-08 US disclosed
WO-2015121212-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY UNIVERSITÀ DEGLI STUDI DI GENOVA (IT) 2015-08-20 WO disclosed
EP-0511865-B1 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents AMERICAN HOME PROD (US) 1997-01-29 EP disclosed
WO-1994027947-A1 PHENYLCYCLOPROPANE COMPOUNDS AND THEIR USE AS cAMP AND TNF INHIBITORS RHONE-POULENC RORER LTD. (GB) 1994-12-08 WO disclosed
EP-0626939-A1 TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1994-12-07 EP disclosed
WO-1994014742-A1 TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CELLTECH LIMITED (GB) 1994-07-07 WO disclosed
US-5274002-A 1-Oxy- or -thio-2-cycloalkyloxy-4-carboxyalkylene benzene derivatives WARNER-LAMBERT COMPANY (US) 1993-12-28 US disclosed
US-5250700-A Phosphodiesterase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1993-10-05 US disclosed
WO-1993015045-A1 N-(3-PHENYLPROPYL)OXAMIC ACID, OXAMATE, AND OXAMIDE DERIVATIVES SMITHKLINE BEECHAM CORPORATION (US) 1993-08-05 WO disclosed
US-5191084-A PHENYL PYRAZOLIDINONES AS BRONCHODILATORS AND ANTI-INFLAMMATORY AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-02 US disclosed
EP-0511865-A1 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents AMERICAN HOME PRODUCTS CORPORATION (US) 1992-11-04 EP disclosed
US-4971959-A Trisubstituted phenyl analogs having activity for congestive heart failure WARNER-LAMBERT COMPANY (US) 1990-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160355489-A1 NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY PDE4A, PDE4D, PDE4B KDM4E 553/4885ALDH1A1 591/4885HPGD 2279/4885
US-10017480-B2 Compounds having a selective PDE4D inhibiting activity PDE4A, PDE4D, PDE2A KDM4E 448/4885ALDH1A1 599/4885HPGD 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.